Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6121 AL 6135

Cannabinoid Receptor 1: The Neural Gatekeeper of Health and Disease

Goyal A, Kumari A, Verma A, Bhatiya S, Yadav HN.

Curr Neurovasc Res. 2025;22(2):100-114. doi: 10.2174/0115672026403497250910124233.

Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on Astrocytes

Pinheiro PSM, Diniz LP, Franco LS, Siqueira M, Gomes FCA.

Pharmaceuticals (Basel). 2025 Sep 30;18(10):1471. doi: 10.3390/ph18101471.

Deep Learning in neuroimaging for neurodegenerative diseases: State-of-the art, Challenges, and Opportunities

Akan T, Akan S, Alp S, Ledbetter CR, Tafti AP, Arevalo O, Bhuiyan MAN.

J Neurol Sci. 2025 Nov 15;478:123735. doi: 10.1016/j.jns.2025.123735. Epub 2025 Oct 24.

Histone Post-Translational Modifications and DNA Double-Strand Break Repair in Neurodegenerative Diseases: An Epigenetic Perspective

Yeasmin A, Torrente MP.

Biology (Basel). 2025 Nov 6;14(11):1556. doi: 10.3390/biology14111556.

Manganese Intoxication Induced by Total Parenteral Nutrition in the Intensive Care Unit: A Case Report

Seijas-Martínez-Echevarría V, Martínez-Manzanal R, Mena-Pérez E, Nuñez-Valentín P, Ruiz-Martin G.

Diagnostics (Basel). 2025 May 27;15(11):1346. doi: 10.3390/diagnostics15111346.

A Comprehensive Review of Therapeutic Compounds from Plants for Neurodegenerative Diseases

Panneerselvam DS, Kanakaraja A, Sakthivelu M, Gopinath SCB, Raman P.

Curr Med Chem. 2025;32(10):1887-1933. doi: 10.2174/0109298673272435231204072922.

Mitochondria-targeted nanotherapeutics: A new frontier in neurodegenerative disease treatment

Keethedeth N, Anantha Shenoi R.

Mitochondrion. 2025 Mar;81:102000. doi: 10.1016/j.mito.2024.102000. Epub 2024 Dec 9.

Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges

Lamichhane S, Seo JE, Jeong JH, Lee S, Lee S.

Arch Pharm Res. 2025 Jan;48(1):62-88. doi: 10.1007/s12272-024-01527-9. Epub 2024 Dec 18.

Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases

Liu Z, Song SY.

Genes (Basel). 2025 Jan 24;16(2):135. doi: 10.3390/genes16020135.

Significance of gene therapy in neurodegenerative diseases

Wang L, Ma L, Gao Z, Wang Y, Qiu J.

Front Neurosci. 2025 May 8;19:1515255. doi: 10.3389/fnins.2025.1515255. eCollection 2025.

Susceptibility-Weighted Imaging (SWI): Technical Aspects and Applications in Brain MRI for Neurodegenerative Disorders

Vaccarino F, Quattrocchi CC, Parillo M.

Bioengineering (Basel). 2025 Apr 29;12(5):473. doi: 10.3390/bioengineering12050473.

Clinical and Mechanistic Exploration of Ellagic Acid in Neurodegenerative Diseases: Targeted Neuroprotection Through Cellular and Molecular Mechanisms

Islam MR, Rauf A, Rahaman MS, Al-Imran MIK, Fakir MNH, Akter S, Akter H, Habiba U, Hussain MS, Al Abdulmonem W, Zengin G, Aljohani ASM.

Chem Biodivers. 2025 Oct;22(10):e00105. doi: 10.1002/cbdv.202500105. Epub 2025 May 30.

RNA Therapeutics: Focus on Antisense Oligonucleotides in the Nervous System

Ertural B, Çiçek BN, Kurnaz IA.

Biomol Ther (Seoul). 2025 Jul 1;33(4):572-581. doi: 10.4062/biomolther.2025.022. Epub 2025 Jun 19.

Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders

Cheng J, Paracha SS, Agrawal S, Wu Z, Sung CH.

Eye Brain. 2025 Jun 14;17:49-67. doi: 10.2147/EB.S516393. eCollection 2025.

Epigenetic reprogramming as a therapeutic strategy for neurodegenerative diseases: A complex and novel approach

Alkhammash A, Alotaibi G.

Eur J Pharmacol. 2025 Sep 5;1002:177853. doi: 10.1016/j.ejphar.2025.177853. Epub 2025 Jun 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias